Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of BLB-750 in Healthy Adults
NCT03370289Phase 4Completed
- Sponsor
- Takeda
- Start
- Jan 2018
- Primary completion
- Feb 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of BLB-750 in Influenza A H5N1 infection (H5N1), sponsored by Takeda. Started Jan 2018; status: completed.
02
Drugs
BLB-750
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT03370289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03370289.